openPR Logo
Press release

Neuromodulation Market to Witness Huge Growth in 2025 | Key Player Analysis: Abbott, Boston Scientific Corporation, Integer Holdings Corporation, Magstim, Medtronic, NeuroPace, Inc., NeuroSigma, Inc.

12-17-2018 04:41 AM CET | Health & Medicine

Press release from: The Insight Partners

Neuromodulation Market to 2025

Neuromodulation Market to 2025

The "Global Neuromodulation Market Analysis to 2025" is a specialized and in-depth study of the Neuromodulation industry with a focus on the global market trend. The report aims to provide an overview of the global Neuromodulation Market with detailed market segmentation by technology, end user, and geography.

Neuromodulation is the process of regulating the activity of nerves by controlling the physiological level of neurotransmitters. These modifications are brought about with the help of various devices or by drug infusion. These devices contain small electrodes that are placed on the spinal cord, brain or the peripheral nerves. Neurological disorders such as, cerebrovascular diseases, Alzheimer disease and Parkinson's disease affect the neurological functioning of the body and hence can be treated with the help of neuromodulation.

Get your Customized Report @ http://bit.ly/2LlqbhP

The "Global Neuromodulation Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global neuromodulation market with detailed market segmentation by technology, end user, and geography. The global neuromodulation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

Profiles of Key Neuromodulation Manufacturing Companies:
1. Abbott
2. Boston Scientific Corporation
3. Integer Holdings Corporation
4. Magstim
5. Medtronic
6. NeuroPace, Inc.
7. NeuroSigma, Inc.
8. Nevro Corp.
9. Synapse Biomedical Inc.
10. Soterix Medical Inc.

The global neuromodulation market is segmented on the basis of technology end user. Based on technology, the neuromodulation market is segmented as, external (non-invasive) neuromodulation and internal neuromodulation. The segment of external (non-invasive) neuromodulation is further classified as, respiratory electrical stimulation (RES), transcutaneous electrical nerve stimulation (TENS) and transcranial magnetic stimulation (TMS). Internal neuromodulation is further classified as, deep brain stimulation (DBS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), spinal cord stimulation (SCS), and vagus nerve stimulation (VNS). Based on end user, neuromodulation market is segmented as, hospitals, clinics and home healthcare.

The neuromodulation market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global neuromodulation market based technology, and end user. It also provides market size and forecast till 2025 for overall neuromodulation market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The neuromodulation market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

Neuromodulation Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.

Buy the complete report with Comprehensive table of contents @ http://bit.ly/2UNvpY1

About Us
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.

Contact us
The Insight partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuromodulation Market to Witness Huge Growth in 2025 | Key Player Analysis: Abbott, Boston Scientific Corporation, Integer Holdings Corporation, Magstim, Medtronic, NeuroPace, Inc., NeuroSigma, Inc. here

News-ID: 1442901 • Views:

More Releases from The Insight Partners

Orthopedic 3D Scanners Market Is Gaining Huge Growth In Upcoming Years
Orthopedic 3D Scanners Market Is Gaining Huge Growth In Upcoming Years
3D orthopaedic scanning devices are sophisticated technology-driven systems used to scan human body components for the detection and treatment of the defect. By means of its scanning capabilities, 3D orthopaedic scanning systems help to design uniquely customised products and to find further use in surgical procedures. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00017457/?utm_source=OpenPR&utm_medium=10129 Orthopedic 3D Scanners Market: Competitive Landscape and Key Developments: • Delcam Plc • Allied OSI Labs • SCANNY3D S.r.l. • AGE Solutions S.r.l. • Orthopaedic Innovation Centre • Diasu
Prostate Cancer Diagnostics: A Guide to Understanding the Process
Prostate Cancer Diagnostics: A Guide to Understanding the Process
Prostate cancer diagnostics refers to the various tests and procedures used to diagnose prostate cancer in men. Early detection of prostate cancer is important for successful treatment and recovery. Several different diagnostic tests are available, including digital rectal exams, prostate-specific antigen (PSA) tests, and biopsies. With the increasing prevalence of prostate cancer. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003656/?utm_source=OpenPR&utm_medium=10129 Prostate Cancer Diagnostics Market: Competitive Landscape and Key Developments: • MDxHealth • Telo Genomics Corp
Aerospace Plastics Market Research Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2031
Aerospace Plastics Market Research Insights with Upcoming Trends Segmentation, O …
The Aerospace Plastics Market report by "The Insight Partners" entails detailed information regarding the dynamics affecting market valuation over the analysis period. It also covers the competitive landscape, market scope, and market segmentation. Get Sample Copy of Report at: https://www.theinsightpartners.com/sample/TIPRE00005464/?utm_source=OpenPR&utm_medium=10188 Companies Profiled in this report includes: • SABIC • Victrex • Drake Plastics Ltd • Solvay • BASF SE • Evonik Industries AG • Vantage Plane Plastics • Paco Plastics & Engineering Inc. • 3P • Performance Plastics Products • Big Bear Plastics The report scrutinizes different business approaches and frameworks that
Consumer Genomics: A Guide to Understanding the Process
Consumer Genomics: A Guide to Understanding the Process
Consumer genomics market is growing as it is very frictionless. A patient can purchase a genetic test online and then receive a test kit by mail and collect a DNA sample in their own home. Patients will receive the results at home and don't need any guidance of a genetic counselor or medical practitioner. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00006429/?utm_source=OpenPR&utm_medium=10129 Consumer Genomics Market: Competitive Landscape and Key Developments: •

All 5 Releases


More Releases for Neuromodulation

Internal Neuromodulation Market 2022 | Detailed Report
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the Internal Neuromodulation market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in the report. This report is
Neuromodulation Devices Market 2022 | Detailed Report
The Neuromodulation Devices research report provides a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The data thus presented is reliable, comprehensive and the result of extensive research both primary and secondary. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. Moreover, the data underlines the primary and secondary drivers,
Neuromodulation Market Overview and Industry Outlook 2020
Global Neuromodulation Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters. This Neuromodulation Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes the projected
Neuromodulation Market Thriving Worldwide $11,717 Million By 2022
The global neuromodulation market size is expected to reach $11,717 million by 2022, registering a CAGR of 13.1% from 2016 to 2022. The global neuromodulation devices market is estimated to reach $11,717 million by 2022. For More Info, Get PDF Sample : http://bit.ly/2BciOaa Neurological disorders such as epilepsy, Alzheimer disease, cerebrovascular diseases, and Parkinson's disease affect the central and peripheral nervous system. Bacterial, viral, and fungal infections
Global Neuromodulation Devices Market 2027: Comprehensive Report Study
Market Research Future published a research report on “Global Neuromodulation Devices Market Research Report- Forecast To 2027” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2027. Global neuromodulation devices market Information, by types by Techniques Applications - Forecast to 2027 Globally the market for neuromodulation devices is increasing rapidly. The major factor that derives the growth of neuromodulation devices is the increasing development neuromodulation devices. Furthermore increasing demand
Sacral Neuromodulation Systems Market Outlook to 2025
Sacral neuromodulation, also known as sacral nerve stimulation, is a type of electrical stimulation. Sacral neuromodulation system is an implanted system that can help improve the functioning of the bladder by sending electrical signals to the nerves, which control bladder activities. According to a study on neuromodulation devices and therapies, neuromodulation is a safe, effective, and long term treatment for chronic pain and movement disorders. Neuromodulation technology is gaining momentum